Construction of VPR_dCas9 Expression Plasmid
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Novo Nordisk (United States)
Other organizations : Ajou University, Korea Advanced Institute of Science and Technology
Protocol cited in 2 other protocols
Variable analysis
- Construction of gRNA vectors using Uracil-Specific Excision Reagent (USER) friendly cloning
- Generation of CHO codon-optimized dCas9 cassette from synthesized CHO codon-optimized wild-type Cas9
- Fusion of CHO codon-optimized dCas9 to a VPR domain cloned from an AAV_NLS-SaCas9-NLS-VPR vector
- Not explicitly mentioned
- Not explicitly mentioned
- Positive control: None mentioned
- Negative control: None mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!